tiprankstipranks
Trending News
More News >
Enliven Therapeutics (ELVN)
NASDAQ:ELVN
US Market
Advertisement

Enliven Therapeutics (ELVN) Revenue

Compare
304 Followers

Enliven Therapeutics Revenue

Enliven Therapeutics had a revenue of 0.00 in the quarter ending Jun 30, 2025, with ―. This bring the company's revenue in the last twelve months to 316.00K, Decreased 0.00%. In the fiscal year ending Dec 31, 2024, Enliven Therapeutics had annual revenue of 0.00 with ― growth.
Revenue (ttm)
316.00K
Revenue Growth
P/S Ratio
Revenue/Employee
$0
Employees
62
Market Cap
$1.17B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis